A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer

City of Hope Comprehensive Cancer Center, Duarte, California, United States

UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States

Medstar Georgetown Cancer Institute, Washington D.C., District of Columbia, United States

Mount Sinai Comprehensive Cancer Center, Miami Beach, Florida, United States

University of Chicago, Chicago, Illinois, United States

University of Kansas Cancer Center, Westwood, Kansas, United States

Maine Medical Center, Scarborough, Maine, United States

Dana Farber Cancer Institute, Boston, Massachusetts, United States

University of Minnesota, Minneapolis, Minnesota, United States

Washington University School of Medicine Siteman Cancer Center, St Louis, Missouri, United States

Nebraska Methodist Hospital, Omaha, Nebraska, United States

Englewood Health, Englewood, New Jersey, United States

Atlantic Health Systems/Morristown Medical Center, Morristown, New Jersey, United States

Roswell Park, Buffalo, New York, United States

Weill Cornell Medicine, New York, New York, United States

Duke University Cancer Center, Durham, North Carolina, United States

University of Oklahoma Health Stephenson Cancer Center, Oklahoma City, Oklahoma, United States

Providence Portland Cancer Institute, Portland, Oregon, United States

University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States

Lifespan - Rhode Island Hospital, Providence, Rhode Island, United States

Baptist Memorial Hospital, Memphis, Tennessee, United States